Search News
-
Bio Jobs | News | 0 Comment
Apply NOW ! Novartis GDD (Global Drug Development) oversees the development of new medicines discovered by our research...Read more
-
Sandoz launches oncology generic gefitinib in 13 EU countries
Generics | News | 0 Comment
Sandoz has announced the launch of the generic oncology medicine gefitinib indicated for adult patients with locally adv...Read more
-
Sandoz receives regulatory approval from NMPA for Rosuvastatin
Generics | News | 0 Comment
Sandoz has announced that it has received regulatory approval from China's National Medical Products Administration (NMP...Read more
-
EirGenix inks commercialization agreement with Sandoz
Generics | News | 0 Comment
EirGenix, Inc. has entered into a license agreement with global generic and biosimilar drug manufacturer Sandoz AG, gran...Read more
-
Sandoz launches SYMJEPI™ (epinephrine) in US
World | News | 0 Comment
Adamis Pharmaceuticals Corporation has announced that its marketing and commercial partner, Sandoz Inc. (Sando...Read more
-
Sandoz and Pear Therapeutics announce US Launch of reSET-OTM
Healthcare | News | 0 Comment
Sandoz Inc., a Novartis division, and Pear Therapeutics has announced the US commercial launch of reSET-O(TM) for patien...Read more
-
Sandoz inks biosimilars commercialization deal with Gan & Lee Pharmaceutical
China | News | 0 Comment
Sandoz, recently announced that it has entered into an agreement with Gan & Lee Pharmaceutical to commerci...Read more
-
Sandoz, Pear Therapeutics announce launch of reSET
World | News | 0 Comment
Sandoz, a Novartis division, and Pear Therapeutics, Inc., has announced the commercial launch of reSET for patients with...Read more
-
Sandoz to focus on more lucrative markets
World | News | 0 Comment
Novartis’ Sandoz division recently announced that it was no longer pursuing US approval for Rixathon, its biosimil...Read more
-
Sandoz receives US FDA approval for biosimilar Hyrimoz
Pharma | News | 0 Comment
Sandoz, a Novartis division and the pioneer and global leader in biosimilars, has announced that the US Food and Drug Ad...Read more
